Mounjaro is not specifically contraindicated in Crohn's disease, but its gastrointestinal side effects may complicate symptom monitoring
tirzepatide lowered HbA 1c by 2.01 to 2.30 percentage points versus 1.86 for semaglutide, meeting non-inferiority and superiority, with greater weight loss as well
The body reads a large calorie deficit and rapid weight loss as physiological stress
Additional Water: The tour only provides water during sharing meals
Lundsen T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE, et al
Understanding the Power of GLP-1 Therapy Chicago GLP-1 therapy Chicago represents a significant leap forward in the treatment of weight management and metabolic health issues